Last update: 22 July 2011 (data as of 20-July-2011)
Next overall update: August 2011
Vaccine schedule selection form
Click to download the immunization schedule whole data set spreadsheet (2.5MB)
 
Schedule for selected antigen: All.
For selected region 'AMR'
Region Country Antigen
(or nutritional supplement)
Description Schedule Comments
AMR Antigua and Barbuda DT Tetanus and diphtheria toxoid childrens' dose 5 years;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine 1st dose; +2, +5 months;   adults
    Influenza Influenza 6-35 months;  
    MMR Measles mumps and rubella vaccine 12 months; 5, 15 years;  
    OPV Oral polio vaccine 2, 4, 6, 18 months; 5 years;  
    Td Tetanus and diphtheria toxoid for older children / adults 1st dose; + 6 weeks; +6 months; +10 years;  
AMR Argentina BCG Bacille Calmette-Guérin vaccine 7 days;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 6 years;  
    DTwPHiB Diphtheria and tetanus toxoid with whole cell pertussis and Hib vaccine 18 months;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepA Hepatitis A vaccine 1 year;  
    HepB Hepatitis B vaccine birth;   Y11 school children
    HIB Haemophilus influenzae type b vaccine    risk groups
    HPV Human Papillomavirus vaccine    From 2011
    Influenza Influenza <2 years; >65 years;  
    IPV Inactivated polio vaccine    immunocompromised and contacts
    MenC_conj Meningococcal C conjugate vaccine    management of outbreaks
    MMR Measles mumps and rubella vaccine 1, 6 years;  
    MR Measles and rubella vaccine    puerperium
    OPV Oral polio vaccine 2, 4, 6, 18 months; 6 years;  
    Pneumo_conj Pneumococcal conjugate vaccine    risk groups; introduction nationwide in 2011
    Pneumo_ps Pneumococcal polysaccharide vaccine    risk groups
    Td Tetanus and diphtheria toxoid for older children / adults    Pregnant women, adults
    Tdap Tetanus and diphtheria toxoids and acellular pertussis vaccine 11 years;   HCW in charge of children less than 1 year
    Typhoid Typhoid fever vaccine    army
    Varicella Varicella vaccine    risk groups
    YF Yellow fever vaccine 1 year; Part of country risk areas
AMR Bahamas DT Tetanus and diphtheria toxoid childrens' dose 4-5 years;  
    DTaPHepBIPV Diphtheria and Tetanus and Pertussis and Hepatitis B and Polio 2, 4, 6 months;  
    DTaPHibHepIPV Hexavalent diphtheria, tetanus toxoid with acellular pertussis, Hib, hepatitis B and IPV vaccine 2, 4, 6 months;  
    DTaPHibIPV Diphtheria and tetanus toxoid with acellular pertussis, Hib and IPV vaccine 2, 4, 6 months;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 2, 4, 6 months;  
    DTwPHib Diphtheria and tetanus toxoid with whole cell pertussis and Hib vaccine 15 months;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine    unvaccinated
    HIB Haemophilus influenzae type b vaccine 2, 4, 6 months;  
    Influenza Influenza    risk population
    IPV Inactivated polio vaccine 2, 4, 6 months; 4-5 years;  
    MMR Measles mumps and rubella vaccine 1, 4-5 years;   Second dose given at 11 years for defaulters
    OPV Oral polio vaccine 2, 4, 6 months; 4-5 years;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 6 months;   & risk population
    Td Tetanus and diphtheria toxoid for older children / adults 10 years;  
AMR Barbados BCG Bacille Calmette-Guérin vaccine 5 years;  
    DT Tetanus and diphtheria toxoid childrens' dose 5-7 years;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months; 4.5 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 3, 4, 6 months;  
    HepB Hepatitis B vaccine    adults
    Influenza Influenza  Part of country at risk persons and HCW
    IPV Inactivated polio vaccine 2, 4, 6, 18 months; 4.5, 10-11 years;   children with HIV mothers
    MMR Measles mumps and rubella vaccine 1, 3-5 years;  
    OPV Oral polio vaccine 2, 4, 6, 18 months; 4.5, 10-11 years;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 6 months;  
    Td Tetanus and diphtheria toxoid for older children / adults 10-11 years;  
    Varicella Varicella vaccine >=18 years;   special groups
    YF Yellow fever vaccine >= 1 year;   Travelers
AMR Belize BCG Bacille Calmette-Guérin vaccine birth;  
    DT Tetanus and diphtheria toxoid childrens' dose 2, 4, 6 months; 4-5 years;   contrindication to pertussis
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 4-5 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine 2, 4, 6 months;   children with contrindication to pertussis and adults at risk
    HPV Human Papillomavirus vaccine    From 2012
    Influenza Influenza 6-24 months (x2 doses); > 65 years;   and chronic ill >9 years and Health Workers
    IPV Inactivated polio vaccine 2, 4, 6 months; 4-5 years;   HIV Exposed infants
    MMR Measles mumps and rubella vaccine 1, 2 years;  
    OPV Oral polio vaccine 2, 4, 6 months; 4-5 years;  
    Td Tetanus and diphtheria toxoid for older children / adults 10 years;   school children 10-14 years
    VitaminA Vitamin A supplementation 6, 12, 18, 24, 30, 36 months;  
    YF Yellow fever vaccine > 1 year;   Travellers to endemic countries
AMR Bolivia (Plurinational State of) BCG Bacille Calmette-Guérin vaccine birth;  
    DTwPHep Diphtheria and tetanus toxoid with whole cell pertussis and HepB vaccine 2, 4, 6 months;  
    DTwPHibHepIPV Hexavalent diphtheria, tetanus toxoid with whole cell pertussis, Hib, hepatitis B and IPV vaccine 2, 4, 6 months;  
    Influenza Influenza    risk groups
    MMR Measles mumps and rubella vaccine 12-23 months;  
    OPV Oral polio vaccine 2, 4, 6 months;  
    Rotavirus Rotavirus vaccine 2, 4 months;  
    Td Tetanus and diphtheria toxoid for older children / adults 1st contact; +1, +6 months; +1, +1 year;  
    VitaminA Vitamin A supplementation 6-11 months;  
    YF Yellow fever vaccine 12-23 months;  
AMR Brazil BCG Bacille Calmette-Guérin vaccine birth;   and natives and natives and contact with leprosis
    DT Tetanus and diphtheria toxoid childrens' dose 2, 4, 6 months;   replacing DTP in case of adverse event
    DTaP Diphtheria and tetanus toxoid with acellular pertussis vaccine 2, 4, 6 months;   special groups
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 15 months; 4-6 years;  
    DTwPHib Diphtheria and tetanus toxoid with whole cell pertussis and Hib vaccine 2, 4, 6 months;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepA Hepatitis A vaccine 12, 18 months;   special groups
    HepB Hepatitis B vaccine birth; 1, 6 months;   children, adolescents and risk groups
    Hib Haemophilus influenzae type b vaccine 2, 4, 6, 15 months;   Special groups
    Influenza Influenza 6 months to 9 years (x2 doses); >= 60 years;  
    IPV Inactivated polio vaccine 2, 4, 6, 15 months;   special groups
    MenAC Meningococcal AC >= 2 years; Part of country when indicated
    MenC_conj Meningococcal C conjugate vaccine 3, 5 months; > 1 years;   and special groups
    MMR Measles mumps and rubella vaccine 12 months; > 4 years;   and adolescents and adults
    OPV Oral polio vaccine 2, 4, 6, 15 months;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 6, 15 months;  
    Pneumo_ps Pneumococcal polysaccharide vaccine >2Y, 7Y and >60 years;   special groups
    Rotavirus Rotavirus vaccine 35, 97 days;  
    Td Tetanus and diphtheria toxoid for older children / adults >7 years (x4);  
    Typhoid Typhoid fever vaccine >=2 years(x2 doses);   Special groups
    Varicella Varicella vaccine 12, 14 months;   special groups and natives
    YF Yellow fever vaccine 9 months; 10 years; Part of country where indicated
AMR Canada BCG Bacille Calmette-Guérin vaccine    BCG-Infants & children belonging to groups with high rates of infection
    DTaPHibIPV Diphtheria and tetanus toxoid with acellular pertussis, Hib and IPV vaccine 2, 4, 6, 18 months;  
    DTaPIPV Diphtheria and tetanus toxoid with acellular pertussis, and IPV vaccine 4-6 years;  
    DTPHibIPV Pentavalent diphtheria and tetanus toxoid with pertussis, Hib and IPV vaccine 2, 4, 6, 18 months;  
    DTwPHib Diphtheria and tetanus toxoid with whole cell pertussis and Hib vaccine 2, 4, 6, 18 months;  
    HepA Hepatitis A vaccine    high risk groups
    HepB Hepatitis B vaccine 1st contact; +1, >+2 months;   Early infancy (3 doses) or pre-teen (2-3 doses)
    HPV Human Papillomavirus vaccine 1st contact; +2, +6 months;  
    Influenza Influenza 6-23 months and >65 years;   and risk groups
    MenC_conj Meningococcal C conjugate vaccine 2, 4, 6 months;   or 2, 4, 12 months;
    MMR Measles mumps and rubella vaccine 12, 18 months; or 4-6 years;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 6, 12-15 months;  
    Pneumo_ps Pneumococcal polysaccharide vaccine >=65 years;  
    Td Tetanus and diphtheria toxoid for older children / adults    every 10 years
    Tdap Tetanus and diphtheria toxoids and acellular pertussis vaccine 14-16 years;  
    Varicella Varicella vaccine 12 months;   Recommended for susceptible older children, adolescents and adults
AMR Chile BCG Bacille Calmette-Guérin vaccine birth;  
    DT Tetanus and diphtheria toxoid childrens' dose 7 years;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 4 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6, 18 months;  
    Influenza Influenza    Adults and risk groups
    MMR Measles mumps and rubella vaccine 12 months; 6 years;  
    OPV Oral polio vaccine 2, 4, 6, 18 months;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 6 months;   special groups
    Pneumo_ps Pneumococcal polysaccharide vaccine 65 years;  
AMR Colombia BCG Bacille Calmette-Guérin vaccine birth;  
    DT Tetanus and diphtheria toxoid childrens' dose 2, 4, 6, 18 months; 5 years;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months; 5 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepA Hepatitis A vaccine 1 year;   risk groups
    HepB Hepatitis B vaccine birth;  
    Influenza Influenza 6-23 months; +4 weeks; 18-23 months; >60 years;  
    IPV Inactivated polio vaccine 2, 4, 6, 18 months; 5 years   immunocompromised
    MMR Measles mumps and rubella vaccine 1, 5 years;  
    MR Measles and rubella vaccine 1-8 years;   MR day
    OPV Oral polio vaccine 2, 4, 6, 18 months; 5 years;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 12 months; Part of country and for risk groups in the parts of the country where not introduced
    Rotavirus Rotavirus vaccine 2, 4 months;  
    Td Tetanus and diphtheria toxoid for older children / adults 1st contact; +1, +6 months;+1, +1 years;   For CBAW or pregnant
    YF Yellow fever vaccine 1 year;   and for people from risk areas and travellers
AMR Costa Rica BCG Bacille Calmette-Guérin vaccine birth;  
    DTaPHibIPV Diphtheria and tetanus toxoid with acellular pertussis, Hib and IPV vaccine 2, 4, 6, 15 months;  
    DTaPIPV Diphtheria and tetanus toxoid with acellular pertussis, and IPV vaccine 4 years;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 4, 15 months; 4 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 6 months;  
    H1N1 A flu    Risk groups
    HepB Hepatitis B vaccine birth; 2, 6 months;   and adults at risk
    Hib Haemophilus influenzae type b vaccine 4, 15 months;  
    Influenza Influenza > 65 years;   and children at risk (6 months to 3 years)
    IPV Inactivated polio vaccine 2, 4, 6 months; 4 years;  
    MMR Measles mumps and rubella vaccine 15 months; 6-7 years;  
    OPV Oral polio vaccine 2, 4, 6 months;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 6, 15 months;  
    Pneumo_ps Pneumococcal polysaccharide vaccine    risk groups
    Rabies Rabies vaccine    risk groups
    Td Tetanus and diphtheria toxoid for older children / adults 7 years;   every 10 years
    Varicella Varicella vaccine 15 months;  
AMR Cuba BCG Bacille Calmette-Guérin vaccine 2 months;  
    DT Tetanus and diphtheria toxoid childrens' dose 6 years;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine birth;  
    Hib Haemophilus influenzae type b vaccine 18 months;  
    Influenza Influenza > 85 years;   and risk groups
    MenBC Meningococcal group B & group C vaccine 3, 5 months;  
    MMR Measles mumps and rubella vaccine 12 months; 6 years;  
    OPV Oral polio vaccine <1, 1, 2, 9 years;  
    TT Tetanus toxoid 15 years;  
    Typhoid Typhoid fever vaccine 10, 13, 16 years;  
AMR Dominica BCG Bacille Calmette-Guérin vaccine birth-2 months;  
    DT Tetanus and diphtheria toxoid childrens' dose 3 years;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months; 3-5 years;   From April 2011
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine 1st contact; +4 weeks; +6 months;   19-39 years, From April 2011
    MMR Measles mumps and rubella vaccine 12, 18 months;  
    OPV Oral polio vaccine 2, 4, 6 months; 3, 13 years;  
    Td Tetanus and diphtheria toxoid for older children / adults 13 years;  
AMR Dominican Republic BCG Bacille Calmette-Guérin vaccine birth;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 2, 4, 6, 18 months; 3, 5 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine birth;   and risk groups at contact, +1, +6 months
    Influenza Influenza 6, 12, 24 months; 18-65 years; > 65 years;  
    MenACWY Meningococcal ACWY    risk groups
    MM Measles and mumps vaccine    suspected cases
    MMR Measles mumps and rubella vaccine 12 months; 5 years;  
    OPV Oral polio vaccine 2, 4, 6, 18 months; 3, 5 years  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 6, 12 months;   Risk groups
    Pneumo_ps Pneumococcal polysaccharide vaccine 65 years;  
    Td Tetanus and diphtheria toxoid for older children / adults 7, 10, 20, 30, 40, 50 years;   CBAW and pregnant women
    Typhoid Typhoid fever vaccine    risk groups
    Varicella Varicella vaccine 12 months;  
    VitaminA Vitamin A supplementation 6, 12, 18, 24 months;  
    YF Yellow fever vaccine >= 6 months;   travellers and risk groups
AMR Ecuador BCG Bacille Calmette-Guérin vaccine birth;  
    DT Tetanus and diphtheria toxoid childrens' dose 5 years;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine 1st contact; +1, +6 months;   At risk
    Influenza Influenza > 65 years;  
    MenAC Meningococcal AC    risk groups only
    MMR Measles mumps and rubella vaccine 12 months; 6 years;  
    OPV Oral polio vaccine 2, 4, 6, 18 months;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 6 months;   From August 2010
    Pneumo_ps Pneumococcal polysaccharide vaccine 65 years;  
    Rotavirus Rotavirus vaccine 2, 4 months;  
    Td Tetanus and diphtheria toxoid for older children / adults 1st contact; +1, +6 months; +1 year;   then every 10 years
    Varicella Varicella vaccine 6, 10 years;  
    YF Yellow fever vaccine 1 year;   >1 year in the amazon region
AMR El Salvador BCG Bacille Calmette-Guérin vaccine birth;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 12 months; 4 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine birth;  
    Influenza Influenza 6-23 months; >= 60 years;  
    IPV Inactivated polio vaccine    children immunocompromised
    MMR Measles mumps and rubella vaccine 12 months; 4 years;  
    OPV Oral polio vaccine 2, 4, 6, 12 months; 4 years;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 6, 15-18 months;  
    Pneumo_ps Pneumococcal polysaccharide vaccine    Chronic diseases
    Rotavirus Rotavirus vaccine 2, 4 months;  
    Td Tetanus and diphtheria toxoid for older children / adults    Adults
AMR Grenada DT Tetanus and diphtheria toxoid childrens' dose 4-5 years;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 6, 16-20, 24-28 weeks;  
    HepB Hepatitis B vaccine > 18 years (x3);   at risk groups and Health Care Workers
    Influenza Influenza 6, 7 months:   Influenza
    MMR Measles mumps and rubella vaccine 12, 18 months;   and adults
    OPV Oral polio vaccine 6-8, 16-20, 24-28 weeks; 18 months; 4-5, >14 years;  
    Td Tetanus and diphtheria toxoid for older children / adults >7 years (x2);  
AMR Guatemala BCG Bacille Calmette-Guérin vaccine birth;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months; 4 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine birth;  
    Influenza Influenza >= 50 years;   and HCWs
    MMR Measles mumps and rubella vaccine 12 months;  
    OPV Oral polio vaccine 2, 4, 6, 18 months; 4 years;  
    Rotavirus Rotavirus vaccine 2, 4, 6 months;   3rd dose introduced in February 2010
    Td Tetanus and diphtheria toxoid for older children / adults 1st contact; +4 weeks; +6 months; +1, +1 year;   or 1st contact; +4 weeks; +6 months; +10, +10 years (if not at risk)
    VitaminA Vitamin A supplementation 6, 12, 18, 24, 30, 36 months;  
AMR Guyana BCG Bacille Calmette-Guérin vaccine birth;  
    DT Tetanus and diphtheria toxoid childrens' dose    pregnant women
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    IPV Inactivated polio vaccine 2, 4, 6, 18, 45 months;   immunosupressed
    MenACW Meningococcal ACW  Part of country risk groups
    MMR Measles mumps and rubella vaccine 12, 45 months;  
    OPV Oral polio vaccine 2, 4, 6, 18, 45 months;  
    Pneumo_conj Pneumococcal conjugate vaccine 2,4,6 months; Part of country immuno suppressed
    Rotavirus Rotavirus vaccine 2, 4, 6 months;  
    Tdap Tetanus and diphtheria toxoids and acellular pertussis vaccine  Part of country high risk
    YF Yellow fever vaccine 12 months;  
AMR Haiti BCG Bacille Calmette-Guérin vaccine birth;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 6, 10, 14 weeks;  
    MR Measles and rubella vaccine 9 months;  
    OPV Oral polio vaccine <15 days, 6, 10, 14 weeks;  
    Td Tetanus and diphtheria toxoid for older children / adults 15 years; +1, +6 months; +1, +5 years;   Women 15-49Y
    VitaminA Vitamin A supplementation 6,10,14, 18, 30, 42 months;  
AMR Honduras BCG Bacille Calmette-Guérin vaccine birth;  
    DT Tetanus and diphtheria toxoid childrens' dose 4, 6, 18 months; 4 years;   pertussis contrindication
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months; 4 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine birth; 1st contact, +1, +6 months;   birth dose and adults
    Influenza Influenza 6-35 months; > 60 years;   HCW, chronic diseases
    IPV Inactivated polio vaccine 2, 4, 6, 18, months;   immunocompromised
    MMR Measles mumps and rubella vaccine 12 months;  
    OPV Oral polio vaccine 2, 4, 6, 18 months;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 6, 12 months;   From April 2011
    Rotavirus Rotavirus vaccine 2, 4 months;  
    Td Tetanus and diphtheria toxoid for older children / adults 11 years;   and pregnant women
    VitaminA Vitamin A supplementation 6, 12, 18, 24, 30, 36 months;  
    YF Yellow fever vaccine >1 year;   international travellers
AMR Jamaica BCG Bacille Calmette-Guérin vaccine birth- 6 weeks;  
    DT Tetanus and diphtheria toxoid childrens' dose 6 weeks; 3, 5-6, 18 months; 4-6 years;   Pertussis contrindication
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months; 4-6 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 6 weeks; 3, 5-6 months;  
    HepB Hepatitis B vaccine 6 weeks; 3, 6 months   or 1st contact, + 4weeks, +6 months (for at risk persons)
    HIB Haemophilus influenzae type b vaccine 6 weeks; 3, 6 months;   pertussis contrindication
    Influenza Influenza    Health workers & high risk person & children with chronic diseases
    IPV Inactivated polio vaccine 6 weeks; 3, 5-6, 18 months; 4-6 years;   immunocompromised
    MMR Measles mumps and rubella vaccine 12-23 months; 4-6 years;   and postnatal women
    OPV Oral polio vaccine 6 weeks; 3, 5-6, 18 months; 4-6 years;  
    Pneumo_conj Pneumococcal conjugate vaccine 2,4,6 months   Children with sickle cell disease
    Td Tetanus and diphtheria toxoid for older children / adults 1st contact; +4 weeks; +6 montha, +1, +1 year   >7 years and pregnent women
    YF Yellow fever vaccine    travellers to endemic countries
AMR Mexico BCG Bacille Calmette-Guérin vaccine birth;  
    DTaP Diphtheria and tetanus toxoid with acellular pertussis vaccine 2, 4 years;  
    DTaPHibIPV Diphtheria and tetanus toxoid with acellular pertussis, Hib and IPV vaccine 2, 4, 6, 18 months;  
    HepB Hepatitis B vaccine birth; 2, 6 months;   and > 12 years (x2 doses)
    HPV Human Papillomavirus vaccine 12 years (x2 doses); 15 years; Part of country 125 municipalities with the lowest Human Development Index
    Influenza Influenza 6-35 months (x2); >60 years  
    MMR Measles mumps and rubella vaccine 1, 6 years;  
    MR Measles and rubella vaccine >12 years;   13-39 years
    OPV Oral polio vaccine > 6 months; < 5 Years;   6 doses
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 12 months;  
    Pneumo_ps Pneumococcal polysaccharide vaccine 65 years;  
    Rotavirus Rotavirus vaccine 2, 4 months;  
    Td Tetanus and diphtheria toxoid for older children / adults 11-12 years (x2); >12 years (x4)   6th grade and and pregnant women
    VitaminA Vitamin A supplementation 6-59 months (x2); Part of country
AMR Nicaragua BCG Bacille Calmette-Guérin vaccine birth;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months; 6 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine 1st contact; +1, +5 months;   HCW and 13 years old adlolescents
    Influenza Influenza 6 months - 4 years;   and > = Y65 with chronic disease, pregnant women and HCW
    MMR Measles mumps and rubella vaccine 1 year;  
    OPV Oral polio vaccine 2, 4, 6 months;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 6 months;   From January 2011
    Pneumo_ps Pneumococcal polysaccharide vaccine >= 50 years;  
    Rotavirus Rotavirus vaccine 2, 4, 6 months;  
    Td Tetanus and diphtheria toxoid for older children / adults 10, 20 years;   CBAW
    VitaminA Vitamin A supplementation 6 months; 1, 2, 3, 4 years;  
    YF Yellow fever vaccine    travellers
AMR Panama BCG Bacille Calmette-Guérin vaccine birth;  
    DT Tetanus and diphtheria toxoid childrens' dose <5 years;   Children with contraindication to pertussis
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 5 years;  
    DTwPHib Diphtheria and tetanus toxoid with whole cell pertussis and Hib vaccine 18 months  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    H1N1 A flu    December 2009
    HepA Hepatitis A vaccine 12, 18 months;  
    HepB Hepatitis B vaccine birth;   Also Studients, adolescents, HCW
    HPV Human Papillomavirus vaccine 10 years; +1, +6 months;  
    Influenza Influenza 6, 7-11 months; >60 years;   HCW and risk groups
    IPV Inactivated polio vaccine 2, 4, 6, 15-18 months; 4-5 years;   HIV+
    MMR Measles mumps and rubella vaccine 12 months; 4 years;  
    MR Measles and rubella vaccine >19Y   CBAW, HCW, general population not vaccinated with MMR before.
    OPV Oral polio vaccine 2, 4, 6, 18 months; 5 years;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 6, 12-15 months; Part of country and risk groups
    Pneumo_ps Pneumococcal polysaccharide vaccine > 60 years;   risk groups
    Rotavirus Rotavirus vaccine 2, 4 months  
    Td Tetanus and diphtheria toxoid for older children / adults    >6Y, CBAW, HCW
    Tdap Tetanus and diphtheria toxoids and acellular pertussis vaccine 11 years;   And risk groups
    VitaminA Vitamin A supplementation 6, 12, 18 month;  
    YF Yellow fever vaccine 1 year; Part of country high risk areas, every 10 years
AMR Paraguay BCG Bacille Calmette-Guérin vaccine birth;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months; 4 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepA Hepatitis A vaccine  Part of country From January 2011
    HepB Hepatitis B vaccine 1st contact; +1, +6 months;   adults at risk
    Influenza Influenza 6-35 (x2) and >60 years;   and risk groups
    IPV Inactivated polio vaccine 2, 4, 6, 18 months;   risk groups
    MenAC Meningococcal AC    risk groups
    MMR Measles mumps and rubella vaccine 1, 4 years;  
    MR Measles and rubella vaccine >5 years;   risk group
    OPV Oral polio vaccine 2, 4, 6, 18 months; 4 years;  
    Pneumo_ps Pneumococcal polysaccharide vaccine    ridk groups
    Rotavirus Rotavirus vaccine 2, 4 months;  
    Td Tetanus and diphtheria toxoid for older children / adults 1st contact; +1 month; +1, +1, +1 year;   CBAW and >Y7 and risk group
    Typhoid Typhoid fever vaccine    international travels
    Varicella Varicella vaccine    risk groups
    YF Yellow fever vaccine 1 year;  
AMR Peru BCG Bacille Calmette-Guérin vaccine birth;  
    DT Tetanus and diphtheria toxoid childrens' dose 4, 6 months;   pertussis contrindication
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months; 4 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine birth;   and adults when requested
    HIB Haemophilus influenzae type b vaccine 2, 4 months;   pertussis contrindication
    Influenza Influenza 1st contact   population with co morbidity
    IPV Inactivated polio vaccine 2, 4, 6 months;   For children with HIV+ mothers
    MMR Measles mumps and rubella vaccine 12 months; 4 years;  
    MR Measles and rubella vaccine    under 5 years old and susceptible population
    OPV Oral polio vaccine 2, 4, 6 months;  
    Pneumo_conj Pneumococcal conjugate vaccine 3, 5, 12 months;  
    Rotavirus Rotavirus vaccine 2, 4 months;  
    Td Tetanus and diphtheria toxoid for older children / adults 1st contact; +2, +4months;   15% of CBAW
    VitaminA Vitamin A supplementation from 6 months   priority districts
    YF Yellow fever vaccine 15 months;   population at risk zones
AMR Saint Kitts and Nevis BCG Bacille Calmette-Guérin vaccine 0-4 weeks;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 3, 4, 5, 18 months; 4-5 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine 2, 4, 7 months;   and adults at 1st contact, +4 weeks, +7 months
    IPV Inactivated polio vaccine 2, 4, 6, 18 months; 4-5, 16 years   special groups
    MMR Measles mumps and rubella vaccine 1, 2 years;  
    OPV Oral polio vaccine 2, 4, 6, 18 months; 4-5, 16 years;  
    Td Tetanus and diphtheria toxoid for older children / adults 11, 16, 26 years;  
    YF Yellow fever vaccine    travellers to endemic countries
AMR Saint Lucia BCG Bacille Calmette-Guérin vaccine 6 weeks;  
    DT Tetanus and diphtheria toxoid childrens' dose 5 years;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 3, 5, 7 months;  
    HepB Hepatitis B vaccine    at risk
    Influenza Influenza    at risk
    IPV Inactivated polio vaccine 3, 5, 7, 18 months; 5, 11 years;   immunocompromised
    MMR Measles mumps and rubella vaccine 1, 5, 11 years;  
    OPV Oral polio vaccine 3, 5, 7, 18 months; 5, 11 years;  
    Td Tetanus and diphtheria toxoid for older children / adults 11 years;  
    Varicella Varicella vaccine    at risk
    YF Yellow fever vaccine    Travellers
AMR Saint Vincent and the Grenadines BCG Bacille Calmette-Guérin vaccine birth-12 months;  
    DT Tetanus and diphtheria toxoid childrens' dose 4-5, 10-15 years;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18 months;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine birth;   hepatitis b exposed babies and adult
    HIB Haemophilus influenzae type b vaccine 6 months;   babies who received HepB at birth
    IPV Inactivated polio vaccine 2, 4, 6, 18 months; 4-5 years;   HIV+ babies
    MMR Measles mumps and rubella vaccine 1, 4-5 years;  
    OPV Oral polio vaccine 2, 4, 6, 18 months; 4-5 years;  
    Td Tetanus and diphtheria toxoid for older children / adults >10 years;  
    YF Yellow fever vaccine    travellers
AMR Suriname DT Tetanus and diphtheria toxoid childrens' dose 2, 4, 6, 18 months;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 2, 4, 6, 18 months; 5 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine birth;   High risk groups
    Influenza Influenza 6 months - 2 years; 12 years  
    MMR Measles mumps and rubella vaccine 1, 5 years;  
    OPV Oral polio vaccine 2, 4, 6, 18 months; 5 years;  
    Td Tetanus and diphtheria toxoid for older children / adults 7 years;   7 years and older
    YF Yellow fever vaccine 1 year; Part of country children in hinterland
AMR Trinidad and Tobago DT Tetanus and diphtheria toxoid childrens' dose 2, 4, 6 months; 4-5 years;   Children with allergies to Pertussis
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 18, 48-60 months;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6 months;  
    HepB Hepatitis B vaccine > 10 years (x3 doses)  
    HIB Haemophilus influenzae type b vaccine 3, 4, 6 months;   special groups
    Influenza Influenza    children & adults
    IPV Inactivated polio vaccine 2, 4, 5, 18 months: 4-5 years;   HIV positive and immunocompromised infants and childrem
    MenC_conj Meningococcal C conjugate vaccine 3 years +   Children and Adults
    MMR Measles mumps and rubella vaccine 12 months; 4-5 years;  
    OPV Oral polio vaccine 2, 4, 6, 18 months; 4-5 years;  
    Pneumo_conj Pneumococcal conjugate vaccine 2,4,6 months;   High risk Infants only
    Pneumo_ps Pneumococcal polysaccharide vaccine >= 24 months;   Children and Adults
    Td Tetanus and diphtheria toxoid for older children / adults > = 10 years;   school leavers and adults
    YF Yellow fever vaccine 1, 11 years;  
AMR United States of America DTaP Diphtheria and tetanus toxoid with acellular pertussis vaccine 2, 4, 6, 15-18 months; 4-6 years;   Either DtaP or other combination vaccine
    HepA Hepatitis A vaccine 12-23 months;   X 2 doses; And risk groups
    HepB Hepatitis B vaccine birth; 1-2, 6-18 months;   Either monovalent or combination vaccine
    Hib Haemophilus influenzae type b vaccine 2, 4, 6, 12-15 months;   Administered in various combination types of vaccines
    HPV Human Papillomavirus vaccine 11-12 years;   X 3 doses
    Influenza Influenza 6-59 months; > 50 years;   And some risk groups
    IPV Inactivated polio vaccine 2, 4, 6-18 months; 4-6 years;  
    MenC_conj Meningococcal C conjugate vaccine 11-12 years;   And other risk groups
    MMR Measles mumps and rubella vaccine 12-15 months; 4-6 years;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 6, 12-15 months;   Also given to high risk groups after 15 months
    Pneumo_ps Pneumococcal polysaccharide vaccine >=2 years;   and some high risk groups
    Rotavirus Rotavirus vaccine 2, 4, 6 months;   or 2, 4 months depending on the vaccine
    Tdap Tetanus and diphtheria toxoids and acellular pertussis vaccine 11-12 years;  
    Varicella Varicella vaccine 12-18 months; 4-6 years;   also susceptible adults
AMR Uruguay BCG Bacille Calmette-Guérin vaccine birth;  
    DT Tetanus and diphtheria toxoid childrens' dose    contra-indication to pertussis
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 5 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6, 15 months;  
    H1N1 A flu 6 months- 4 years;   PW and chronic diseases
    HepA Hepatitis A vaccine 15, 21 months;   and travellers at risk
    HepB Hepatitis B vaccine 12 years; +1, +6 months;   risk groups and at birth for children with positive mother
    HIB Haemophilus influenzae type b vaccine    contra- indication to pertussis
    Influenza Influenza >55 years;  
    IPV Inactivated polio vaccine    contra-indication to OPV
    MMR Measles mumps and rubella vaccine 12 months; 5 years;  
    OPV Oral polio vaccine 2, 4, 6, 12 months;  
    Pneumo_conj Pneumococcal conjugate vaccine 2, 4, 12 months;   and catch up for less than 5 years
    Pneumo_ps Pneumococcal polysaccharide vaccine > 65 years;   and risk groups
    Rabies Rabies vaccine    risk groups and post exposure
    Td Tetanus and diphtheria toxoid for older children / adults 12 years;   every 10 years
    Varicella Varicella vaccine 12 months;  
    YF Yellow fever vaccine    travellers
AMR Venezuela (Bolivarian Republic of) BCG Bacille Calmette-Guérin vaccine birth;  
    Dip Diphtheria vaccine 0, +1, +6 months; +1, +1 year;  
    DTwP Diphtheria and tetanus toxoid with whole cell pertussis vaccine 5 years;  
    DTwPHibHep Diphtheria and tetanus toxoid with whole cell pertussis, Hib and HepB vaccine 2, 4, 6, 18 months;  
    HepB Hepatitis B vaccine birth;   for risk groups; 1st contact; +2, +4 months;
    Influenza Influenza 6, 7 months;   and >50 years and risk groups
    MenC_conj Meningococcal C conjugate vaccine    risk groups
    MMR Measles mumps and rubella vaccine 12 months; 5 years;  
    OPV Oral polio vaccine 2, 4, 6, 18 months; 5 years;  
    Pneumo_ps Pneumococcal polysaccharide vaccine > 60 years;  
    Rotavirus Rotavirus vaccine 2, 4 months;  
    Td Tetanus and diphtheria toxoid for older children / adults 1st contact; +1, +6 months; +1, +1 year;  
    YF Yellow fever vaccine 12 months;   pre-school and travellers
 
    Source: WHO vaccine-preventable diseases: monitoring system 2011 global summary